Elastomeric Infusion Pumps Market Size, Share & Trends Analysis Report By Product (Continuous Rate Elastomeric Infusion Pumps, Variable Rate Elastomeric Infusion Pumps), By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030
Elastomeric Infusion Pumps Market Trends
The global elastomeric infusion pumps market size was estimated at USD 679.8 million in 2024 and is projected to grow at a CAGR of 7.2% from 2025 to 2030. The rising incidence of chronic diseases such as cancer, diabetes, and cardiovascular disorders is a significant driver for market growth. According to statistics from the World Health Organization (WHO), chronic diseases are the leading cause of mortality worldwide, accounting for 71% of all deaths globally. This led to a higher demand for continuous drug delivery systems such as elastomeric pumps to ensure effective treatment and management of these conditions.
The growing demand for home healthcare solutions is a crucial factor driving the elastomeric infusion pumps industry. Patients prefer therapies that enable them to administer medications at home, and the portability and user-friendliness of elastomeric pumps cater to this need. This trend is amplified by the aging population's increasing requirement for long-term treatment of chronic conditions. According to a study published in October 2024, Osteomyelitis affects around 50,000 people annually in the U.S., with higher incidence in children, older adults, and males. Vertebrae and long bones are the most commonly involved sites. It also shows that males are more susceptible to Osteomyelitis than females, as evidenced by the current research and other published data on the disease.
Manufacturers are focusing on enhancing elastomeric infusion pump technologies to drive market growth. These advancements involve greater accuracy, longer infusion durations, developing pumps with improved features, and accessible designs. These innovations aim to cater to the diverse needs of patients and healthcare providers, enhancing the efficiency of elastomeric infusion pumps and making them dependable and secure. In September 2024, research published in the Journal of Biosciences and Medicines presented a theoretical model for elastomeric pumps, which deliver medications through a catheter. The study accurately reproduced clinical flow rates and identified a toxicity bump related to the sphere's radius. The researchers concluded that by optimizing pump properties, infusion times can be controlled while minimizing toxicity effects.
The increasing push to reduce opioid dependence and improve patient access to alternative pain management solutions has been a major driver in healthcare policy changes. In November 2024, Avanos Medical, Inc. reported that the Centers for Medicare and Medicaid Services has finalized its Medicare Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System regulations for 2025, set to take effect on January 1, 2025. This update introduces the NOPAIN Act, which requires Medicare to provide distinct payments for eligible non-opioid medications and devices to improve patient access to pain management solutions in hospital outpatient and surgical center environments.
Global Elastomeric Infusion Pumps Market Report Segmentation
This report forecasts revenue growth at global, regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global elastomeric infusion pumps market report based on product, application, end-use, and region:
- Product Outlook (Revenue, USD Million, 2018 - 2030)
- Continuous Rate Elastomeric Infusion Pumps
- Variable Rate Elastomeric Infusion Pumps
- Application Outlook (Revenue, USD Million, 2018 - 2030)
- Pain Management
- Chemotherapy
- Antibiotic/Antiviral Therapy
- Others
- End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Ambulatory Surgical Centers
- Others
- Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- South Korea
- Australia
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Application
- 1.2.3. End use
- 1.2.4. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR’s internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Volume price analysis (Model 2)
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Application outlook
- 2.2.3. End use outlook
- 2.3. Competitive Insights
- Chapter 3. Elastomeric Infusion Pumps Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Increasing prevalence of chronic diseases
- 3.2.1.2. Rising number of orthopedic surgeries
- 3.2.1.3. Technological advancements in elastomeric infusion pumps
- 3.2.2. Market restraint analysis
- 3.2.2.1. High cost of elastomeric infusion pumps
- 3.2.2.2. Regulatory standards
- 3.3. Elastomeric Infusion Pumps Market Analysis Tools
- 3.3.1. Industry Analysis - Porter’s
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
- Chapter 4. Elastomeric Infusion Pumps Market: Product Estimates & Trend Analysis
- 4.1. Global Elastomeric Infusion Pumps Market: Product Dashboard
- 4.2. Global Elastomeric Infusion Pumps Market: Product Movement Analysis
- 4.3. Global Elastomeric Infusion Pumps Market by Product, Revenue
- 4.4. Continuous Rate Elastomeric Infusion Pumps
- 4.4.1. Continuous Rate Elastomeric Infusion Pumps market estimates and forecasts, 2018 to 2030 (USD Billion)
- 4.5. Variable Rate Elastomeric Infusion Pumps
- 4.5.1. Variable Rate Elastomeric Infusion Pumps market estimates and forecasts, 2018 to 2030 (USD Billion)
- Chapter 5. Elastomeric Infusion Pumps Market: Application Estimates & Trend Analysis
- 5.1. Global Elastomeric Infusion Pumps Market: Application Dashboard
- 5.2. Global Elastomeric Infusion Pumps Market: Application Movement Analysis
- 5.3. Global Elastomeric Infusion Pumps Market by Application, Revenue
- 5.4. Pain Management
- 5.4.1. Pain management market estimates and forecasts, 2018 to 2030 (USD Billion)
- 5.5. Chemotherapy
- 5.5.1. Chemotherapy market estimates and forecasts, 2018 to 2030 (USD Billion)
- 5.6. Antibiotic/Antiviral Therapy
- 5.6.1. Antibiotic/antiviral therapy market estimates and forecasts, 2018 to 2030 (USD Billion)
- 5.7. Others
- 5.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Billion)
- Chapter 6. Elastomeric Infusion Pumps Market: End Use Estimates & Trend Analysis
- 6.1. Global Elastomeric Infusion Pumps Market: End Use Dashboard
- 6.2. Global Elastomeric Infusion Pumps Market: End Use Movement Analysis
- 6.3. Global Elastomeric Infusion Pumps Market by End Use, Revenue
- 6.4. Hospitals
- 6.4.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Billion)
- 6.5. Ambulatory Surgical Centers
- 6.5.1. Ambulatory surgical centers market estimates and forecasts, 2018 to 2030 (USD Billion)
- 6.6. Others
- 6.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Billion)
- Chapter 7. Elastomeric Infusion Pumps Market: Regional Estimates & Trend Analysis by Country, Product, Application and End Use
- 7.1. Regional Dashboard
- 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
- 7.3. North America
- 7.3.1. U.S.
- 7.3.1.1. Key country dynamics
- 7.3.1.2. Regulatory framework/ reimbursement structure
- 7.3.1.3. Competitive scenario
- 7.3.1.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.3.2. Canada
- 7.3.2.1. Key country dynamics
- 7.3.2.2. Regulatory framework/ reimbursement structure
- 7.3.2.3. Competitive scenario
- 7.3.2.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.3.3. Mexico
- 7.3.3.1. Key country dynamics
- 7.3.3.2. Regulatory framework/ reimbursement structure
- 7.3.3.3. Competitive scenario
- 7.3.3.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.4. Europe
- 7.4.1. UK
- 7.4.1.1. Key country dynamics
- 7.4.1.2. Regulatory framework/ reimbursement structure
- 7.4.1.3. Competitive scenario
- 7.4.1.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.4.2. Germany
- 7.4.2.1. Key country dynamics
- 7.4.2.2. Regulatory framework/ reimbursement structure
- 7.4.2.3. Competitive scenario
- 7.4.2.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.4.3. France
- 7.4.3.1. Key country dynamics
- 7.4.3.2. Regulatory framework/ reimbursement structure
- 7.4.3.3. Competitive scenario
- 7.4.3.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.4.4. Italy
- 7.4.4.1. Key country dynamics
- 7.4.4.2. Regulatory framework/ reimbursement structure
- 7.4.4.3. Competitive scenario
- 7.4.4.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.4.5. Spain
- 7.4.5.1. Key country dynamics
- 7.4.5.2. Regulatory framework/ reimbursement structure
- 7.4.5.3. Competitive scenario
- 7.4.5.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.4.6. Norway
- 7.4.6.1. Key country dynamics
- 7.4.6.2. Regulatory framework/ reimbursement structure
- 7.4.6.3. Competitive scenario
- 7.4.6.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.4.7. Sweden
- 7.4.7.1. Key country dynamics
- 7.4.7.2. Regulatory framework/ reimbursement structure
- 7.4.7.3. Competitive scenario
- 7.4.7.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.4.8. Denmark
- 7.4.8.1. Key country dynamics
- 7.4.8.2. Regulatory framework/ reimbursement structure
- 7.4.8.3. Competitive scenario
- 7.4.8.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.5. Asia Pacific
- 7.5.1. Japan
- 7.5.1.1. Key country dynamics
- 7.5.1.2. Regulatory framework/ reimbursement structure
- 7.5.1.3. Competitive scenario
- 7.5.1.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.5.2. China
- 7.5.2.1. Key country dynamics
- 7.5.2.2. Regulatory framework/ reimbursement structure
- 7.5.2.3. Competitive scenario
- 7.5.2.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.5.3. India
- 7.5.3.1. Key country dynamics
- 7.5.3.2. Regulatory framework/ reimbursement structure
- 7.5.3.3. Competitive scenario
- 7.5.3.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.5.4. Australia
- 7.5.4.1. Key country dynamics
- 7.5.4.2. Regulatory framework/ reimbursement structure
- 7.5.4.3. Competitive scenario
- 7.5.4.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.5.5. South Korea
- 7.5.5.1. Key country dynamics
- 7.5.5.2. Regulatory framework/ reimbursement structure
- 7.5.5.3. Competitive scenario
- 7.5.5.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.5.6. Thailand
- 7.5.6.1. Key country dynamics
- 7.5.6.2. Regulatory framework/ reimbursement structure
- 7.5.6.3. Competitive scenario
- 7.5.6.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.6. Latin America
- 7.6.1. Brazil
- 7.6.1.1. Key country dynamics
- 7.6.1.2. Regulatory framework/ reimbursement structure
- 7.6.1.3. Competitive scenario
- 7.6.1.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.6.2. Argentina
- 7.6.2.1. Key country dynamics
- 7.6.2.2. Regulatory framework/ reimbursement structure
- 7.6.2.3. Competitive scenario
- 7.6.2.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.7. MEA
- 7.7.1. South Africa
- 7.7.1.1. Key country dynamics
- 7.7.1.2. Regulatory framework/ reimbursement structure
- 7.7.1.3. Competitive scenario
- 7.7.1.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.7.2. Saudi Arabia
- 7.7.2.1. Key country dynamics
- 7.7.2.2. Regulatory framework/ reimbursement structure
- 7.7.2.3. Competitive scenario
- 7.7.2.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.7.3. UAE
- 7.7.3.1. Key country dynamics
- 7.7.3.2. Regulatory framework/ reimbursement structure
- 7.7.3.3. Competitive scenario
- 7.7.3.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.7.4. Kuwait
- 7.7.4.1. Key country dynamics
- 7.7.4.2. Regulatory framework/ reimbursement structure
- 7.7.4.3. Competitive scenario
- 7.7.4.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)
- Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Manufacturers
- 8.2. Company/Competition Categorization
- 8.3. Vendor Landscape
- 8.3.1. List of key distributors and channel partners
- 8.3.2. Key customers
- 8.3.3. Key company market share analysis, 2024
- 8.4. Company Profiles
- 8.4.1. Baxter
- 8.4.1.1. Company overview
- 8.4.1.2. Financial performance
- 8.4.1.3. Product benchmarking
- 8.4.1.4. Strategic initiatives
- 8.4.2. Fresenius Kabi AG
- 8.4.2.1. Company overview
- 8.4.2.2. Financial performance
- 8.4.2.3. Product benchmarking
- 8.4.2.4. Strategic initiatives
- 8.4.3. B. Braun SE
- 8.4.3.1. Company overview
- 8.4.3.2. Financial performance
- 8.4.3.3. Product benchmarking
- 8.4.3.4. Strategic initiatives
- 8.4.4. Ambu A/S
- 8.4.4.1. Company overview
- 8.4.4.2. Financial performance
- 8.4.4.3. Product benchmarking
- 8.4.4.4. Strategic initiatives
- 8.4.5. Leventon, S.A.U.
- 8.4.5.1. Company overview
- 8.4.5.2. Financial performance
- 8.4.5.3. Product benchmarking
- 8.4.5.4. Strategic initiatives
- 8.4.6. NIPRO
- 8.4.6.1. Company overview
- 8.4.6.2. Financial performance
- 8.4.6.3. Product benchmarking
- 8.4.6.4. Strategic initiatives
- 8.4.7. Terumo Corporation
- 8.4.7.1. Company overview
- 8.4.7.2. Financial performance
- 8.4.7.3. Product benchmarking
- 8.4.7.4. Strategic initiatives
- 8.4.8. AVNS
- 8.4.8.1. Company overview
- 8.4.8.2. Financial performance
- 8.4.8.3. Product benchmarking
- 8.4.8.4. Strategic initiatives
- 8.4.9. Vygon Group
- 8.4.9.1. Company overview
- 8.4.9.2. Financial performance
- 8.4.9.3. Product benchmarking
- 8.4.9.4. Strategic initiatives
- 8.4.10. Smiths Group plc
- 8.4.10.1. Company overview
- 8.4.10.2. Financial performance
- 8.4.10.3. Product benchmarking
- 8.4.10.4. Strategic initiatives
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook